AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · IEX Real-Time Price · USD
22.52
+1.14 (5.33%)
At close: Mar 28, 2024, 4:00 PM
20.93
-1.59 (-7.06%)
After-hours: Mar 28, 2024, 4:17 PM EDT

AnaptysBio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Revenue
17.1610.2963.1875851016.6817.5715.84
Revenue Growth (YoY)
66.78%-83.72%-15.77%837.50%60.00%-50.00%-40.06%-5.05%10.94%-
Gross Profit
17.1610.2963.1875851016.6817.5715.84
Selling, General & Admin
41.9536.6421.4918.8516.0915.539.344.293.592.35
Research & Development
132.2888.898.580.0399.3456.229.4415.4217.38.61
Other Operating Expenses
7.3400000000-0
Operating Expenses
181.57125.44119.9998.88115.4371.7238.7819.7120.8910.97
Operating Income
-164.41-115.15-56.81-23.88-107.43-66.72-28.78-3.03-3.324.87
Interest Expense / Income
00001.041.651.780.460.461.28
Other Expense / Income
-0.7913.550.98-3.95-10.99-6.53-0.490.781.480.06
Pretax Income
-163.62-128.7-57.8-19.93-97.49-61.85-30.07-4.26-5.273.53
Income Tax
-00.0200-0.15-0.19000.140
Net Income
-163.62-128.72-57.8-19.93-97.34-61.66-30.07-4.26-5.413.53
Preferred Dividends
0000000003.3
Net Income Common
-163.62-128.72-57.8-19.93-97.34-61.66-30.07-4.26-5.410.23
Shares Outstanding (Basic)
27282727272520332
Shares Outstanding (Diluted)
27282727272520332
Shares Change
-4.41%2.68%0.47%0.90%9.67%24.72%650.17%3.37%2.82%-
EPS (Basic)
-6.08-4.57-2.11-0.73-3.60-2.50-1.52-1.62-2.120.09
EPS (Diluted)
-6.08-4.57-2.11-0.73-3.60-2.50-1.52-1.62-2.120.09
Free Cash Flow
-121.61-73.95-47.27-14.73-70.32-49.57-19.73-9.08-9.9314.46
Free Cash Flow Per Share
-4.52-2.63-1.72-0.54-2.60-2.01-1.00-3.44-3.895.83
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-958.27%-1119.41%-89.93%-31.84%-1342.90%-1334.44%-287.81%-18.13%-18.91%30.76%
Profit Margin
-953.66%-1251.33%-91.49%-26.57%-1216.70%-1233.12%-300.70%-25.53%-30.76%1.46%
Free Cash Flow Margin
-708.79%-718.88%-74.83%-19.63%-879.03%-991.38%-197.28%-54.42%-56.52%91.32%
EBITDA
-161.25-126.37-55.71-18.31-95.04-59.88-28.11-3.57-4.535.12
EBITDA Margin
-939.83%-1228.40%-88.18%-24.42%-1188.00%-1197.62%-281.12%-21.39%-25.79%32.33%
Depreciation & Amortization
2.382.342.091.621.410.320.180.230.270.31
EBIT
-163.62-128.7-57.8-19.93-96.45-60.2-28.3-3.8-4.814.81
EBIT Margin
-953.68%-1251.09%-91.49%-26.57%-1205.59%-1203.92%-282.95%-22.78%-27.35%30.39%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).